IMVT
USDImmunovant Inc. Common Stock
$24.190+0.810 (3.464%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$23.380
High
$24.530
Low
$23.310
Volume
1.45M
Company Fundamentals
Market Cap
4.2B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.71M
Exchange
NMS
Currency
USD
52-Week Range
Low $12.72Current $24.190High $32.1
Related News
GlobeNewswire
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Immunovant (NASDAQ:IMVT) today announced that it will report its financial results for the second quarter ended September 30, 2025, and provide a business update at 8:00 a.m.
View more
Analyst Upgrades
Truist Securities Initiates Coverage On Immunovant with Hold Rating, Announces Price Target of $16
Truist Securities analyst Danielle Brill initiates coverage on Immunovant with a Hold rating and announces Price Target of $16.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.